Last reviewed · How we verify
Postpartum Antibiotics
Postpartum Antibiotics is a Small molecule drug developed by Washington University School of Medicine. It is currently FDA-approved.
Postpartum Antibiotics, developed by Washington University School of Medicine, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and the protection afforded by its patent until 2028. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Postpartum Antibiotics |
|---|---|
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants (NA)
- Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan (PHASE2)
- Azithromycin for Preventing Maternal and Neonatal Infections During Labor. (PHASE4)
- Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair (PHASE4)
- Safely Reduce Newborn Antibiotic Exposure With the Early-onset Sepsis Calculator (NA)
- Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
- Lidocaine, Povidone Iodine, and Honey Application on Second-degree Perineal Tear Healing (PHASE4)
- Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Postpartum Antibiotics CI brief — competitive landscape report
- Postpartum Antibiotics updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI
Frequently asked questions about Postpartum Antibiotics
What is Postpartum Antibiotics?
Who makes Postpartum Antibiotics?
What development phase is Postpartum Antibiotics in?
Related
- Manufacturer: Washington University School of Medicine — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing